ABBV News and Press, AbbVie Inc. From 06/05/24

2024-06-05 11:25:00 ET Summary In May, we received a dividend income total of $1,664.04. Consumers are still strong, but earnings have been mixed, to say the least. I received 6 more dividend increases in May 2024, consistent with last month. This is what dividend in...

2024-06-05 10:10:34 ET More on AbbVie AbbVie: Turnaround Lurking After The Correction Pain (Upgrade) AbbVie: This Dividend Aristocrat Is Almost Buyable Again Now Looking For Both Income And Growth? 4%-Yielding AbbVie Has You Covered Emerging and Chinese pharm...

AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for Investigational Asset ABBV-383 PR Newswire ABBV-383 is a B-cell maturation antigen (BCMA) bispecific antibody T-cell engager being evaluated in relapsed/refractory multiple myeloma (r...

2024-06-04 08:52:00 ET When you look at the stock market, valuations can seem stretched for a lot of the megacap names -- not all -- but there are still plenty of deals to be had. In today's video, I will look into a few dividend stocks and one growth stock that look intriguing at current v...

RINVOQ® (upadacitinib) Now Available for Pediatric Patients Two Years and Older with Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis PR Newswire – First indications of RINVOQ (upadacitinib) for pediatric patients two years of age and older 1 ...

Refer Your Friends to Allē, the Loyalty Rewards Program by Allergan Aesthetics, and Earn $50 PR Newswire Join Allē Today to Start Sharing and Earning Rewards Refer a Friend by Allē Lets Consumers Earn up to $50 to Use Towards Allerg...

2024-06-04 04:20:17 ET Summary Cerevel Therapeutics agreed to be acquired by AbbVie on 12/06/23 for $45/s or ~$8.7B. CERE stock closed on Friday, May 31st at $40.74/s. This presents investors with a potential arbitrage play of over 10% on a deal that should close within the next 3...

AbbVie to Present at the Goldman Sachs 45th Annual Global Healthcare Conference PR Newswire NORTH CHICAGO, Ill. , June 3, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June ...

2024-06-02 14:00:00 ET PD-1/PD-L1 inhibitors, some of the most commonly used cancer therapies, achieved $52B in spending worldwide in 2023, a number expected to reach $90B in 2028. Examples include Merck's ( NYSE: MRK ) Keytruda (pembrolizumab), Bristol Myers Squibb's ( NYSE: BM...

2024-06-02 06:00:00 ET You're probably familiar with the old adage, "April showers bring May flowers." And you probably know the punchline to the question, "What do May flowers bring?" (The answer: Pilgrims.) But what does June bring? Three Motley Fool contributors think the new month s...